L-652,343：一种新型的5-脂氧合酶/环氧化酶双重抑制剂。 - Suppr | 超能文献

L-652,343: a novel dual 5-lipoxygenase/cyclooxygenase inhibitor.

作者信息

Tischler A, Bailey P, Dallob A, Witzel B, Durette P, Rupprecht K, Allison D, Dougherty H, Humes J, Ham E

出版信息

Adv Prostaglandin Thromboxane Leukot Res. 1986;16:63-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

L-652,343: a novel dual 5-lipoxygenase/cyclooxygenase inhibitor.L-652,343：一种新型的5-脂氧合酶/环氧化酶双重抑制剂。

Adv Prostaglandin Thromboxane Leukot Res. 1986;16:63-6.

2

Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.

Arzneimittelforschung. 1988 Mar;38(3):372-8.

3

Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.在犬类炎症模型中对双环氧化酶-2选择性/5-脂氧合酶抑制剂RWJ 63556的抗炎活性进行评估。

J Pharmacol Exp Ther. 1997 Aug;282(2):1094-101.

4

Antiinflammatory consequences of 5-lipoxygenase inhibition.5-脂氧合酶抑制的抗炎作用

Adv Prostaglandin Thromboxane Leukot Res. 1986;16:47-62.

5

Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.替泊沙林：一种花生四烯酸代谢的双重环氧化酶/5-脂氧合酶抑制剂，具有强大的抗炎活性和良好的胃肠道耐受性。

J Pharmacol Exp Ther. 1994 Dec;271(3):1399-408.

6

L-651,392: a novel, potent and selective 5-lipoxygenase inhibitor.L-651,392：一种新型、强效且具有选择性的5-脂氧合酶抑制剂。

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:554-7.

7

Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.新型抗炎化合物对大鼠乙酸诱导胃溃疡愈合的影响。

J Pharmacol Exp Ther. 1998 Oct;287(1):301-6.

8

New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.新型环氧化酶-2/5-脂氧合酶抑制剂。3. 作为胃肠道安全性抗炎和镇痛剂的7-叔丁基-2,3-二氢-3,3-二甲基苯并呋喃衍生物：5位的变化

J Med Chem. 1998 Aug 27;41(18):3515-29. doi: 10.1021/jm9802416.

9

Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).一类新型罗非昔布类似物作为环氧化酶（COXs）和脂氧化酶（LOXs）双重抑制剂的合成及生物学评价

Bioorg Med Chem. 2006 Dec 1;14(23):7898-909. doi: 10.1016/j.bmc.2006.07.047. Epub 2006 Aug 10.

10

Effects of a 5-lipoxygenase inhibitor (L-651,392) and leukotriene D4 antagonist (L-649,923) in two animal models of immediate hypersensitivity reactions.5-脂氧合酶抑制剂（L-651,392）和白三烯D4拮抗剂（L-649,923）在两种速发型超敏反应动物模型中的作用。

Adv Prostaglandin Thromboxane Leukot Res. 1987;17B:1007-11.

引用本文的文献

1

Rationally designed multitarget agents against inflammation and pain.针对炎症和疼痛的合理设计的多靶标药物。

Curr Med Chem. 2013;20(13):1783-99. doi: 10.2174/0929867311320130013.